The KMT2A recombinome of acute leukemias in 2023

Abstract

Chromosomal rearrangements of the human KMT2A/MLL gene are associated with de novo as well as therapy-induced infant, pediatric, and adult acute leukemias. Here, we present the data obtained from 3401 acute leukemia patients that have been analyzed between 2003 and 2022. Genomic breakpoints within the KMT2A gene and the involved translocation partner genes (TPGs) and KMT2A-partial tandem duplications (PTDs) were determined. Including the published data from the literature, a total of 107 in-frame KMT2A gene fusions have been identified so far. Further 16 rearrangements were out-of-frame fusions, 18 patients had no partner gene fused to 5’-KMT2A, two patients had a 5’-KMT2A deletion, and one ETV6::RUNX1 patient had an KMT2A insertion at the breakpoint. The seven most frequent TPGs and PTDs account for more than 90% of all recombinations of the KMT2A, 37 occur recurrently and 63 were identified so far only once. This study provides a comprehensive analysis of the KMT2A recombinome in acute leukemia patients. Besides the scientific gain of information, genomic breakpoint sequences of these patients were used to monitor minimal residual disease (MRD). Thus, this work may be directly translated from the bench to the bedside of patients and meet the clinical needs to improve patient survival.

Mapping AML heterogeneity – multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses

“…Interestingly, MLLT3 , MLLT10 and MLLT1 all fuse a specific region of KMT2A , but MLLT4 shows less specificity. 54 Collectively, these results suggest that two types of oncogenic mechanisms involving KMT2A fusions exist that may be marked with unique gene expression patterns.…”

Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease

“…50 KMT2A is also involved in regulation of gene expression and is implicated in different types of leukemia. 51 FMNL3 plays a significant role in actin polymerization, 52,53 regulating cell migration, metastasis and tumor progression. 54 CTNNBIP1 encodes a negative regulator of the Wnt signaling pathway 55 and as the Wnt signaling pathway has been shown to be disrupted in cystic kidney, a potential connection could be hypothesized.…”

Pathophysiology of Acute Myeloid Leukemia

“…For example, Lysine [K]-specific Methyl Transferase 2A (KMT2A) encodes a nuclear protein with methyltransferase activity that is part of a large multifunctional complex. Leukemia-associated translocations involving the N-terminus of the KMT2A gene and over 100 KMT2A fusion partners have been documented in pediatric and adult de novo AML, therapy-related AML, and other acute leukemias [52]. MLLT3, AFDN, ELL, and MLLT10 are the most prevalent fusion partners in adult AML, and the prevalence of fusion partners varies with age and type of leukemia [52].…”